Sleep Apnea Implants Market Expected to Reach $1.3 Billion by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Sleep Apnea Implants Market," The sleep apnea implants market was valued at $0.31 billion in 2021, and is estimated to reach $1.3 billion by 2031, growing at a CAGR of 15.4% from 2022 to 2031.

Sleep apnea is a sleep disorder marked by abnormal reductions in breathing while a person is asleep. These disruptions reduce the quality of sleep and, if left untreated, can lead to potentially serious health consequences. It is a common disorder however often goes undiagnosed as many sleepers are unaware of their nighttime symptoms. People with sleep apnea repeatedly have reductions or pauses in breathing for brief periods while they sleep. Although these lapses cause a person to awaken periodically and reduce sleep quality, sleepers may not fully wake up and remain unaware that their nighttime breathing is abnormal. The proper management of the types of sleep apnea, as well as the symptoms, causes, and treatments, can help people understand this condition and minimize its potential health effects.  

Increase in the prevalence of sleep apnea among the developing countries, rise in the occurrence of sleep deprivation disorders such as obstructive sleep apnea (OSA), surge in demand for sleep apnea implanting devices in the hospitals, and upsurge in the technological advancements of the devices such as hypoglossal neurostimulation devices drive the growth of the Sleep Apnea Implants Market Size. Moreover, increase in the spread of awareness about the adoption of palatal implants and phrenic nerve stimulator contributes to the growth of the Sleep Apnea Implants Market Growth. For instance, according to the study by ResMed in October 2018, approximately 175 million Europeans had obstructive sleep apnea, which is a chronic condition characterized by regular pauses in breathing during sleep, associated with an increased risk of mortality.  

The advancements in the implant devices such as the surgically implanted smart polymers that are an emerging technology, shows the promising benefits in the treatment of airway collapse in obstructive sleep apnea. The Sleep Apnea Implants Market Trends such as technological advancements in the implant devices may enhance features of the devices making it more preferable by the healthcare professionals for treating the sleep apnea condition which further may help in driving the market growth. Moreover, increase in need for surgical care for implants, rise in government expenditure & grants by the government in order to improve the sleep apnea treatment options, rising focus on awareness programs on the use of implant devices among the population and upsurge in the number of hospitals, ambulatory care centers, and emergency care centers also helps in the growth of the market. However, high cost of the devices and problems associated with the use of devices are expected to hinder the growth of this market. Conversely, the high growth potential in untapped emerging economies is expected to create lucrative opportunities for the market. 

The sleep apnea implants market is segmented based on product type, indication, end user, and region. On the basis of product type, the market is fragmented into hypoglossal neurostimulation devices, phrenic nerve stimulator, and others. On the basis of indication, the market is bifurcated into obstructive sleep apnea and central sleep apnea. On the basis of end user, the market is classified into hospitals, ambulatory surgery center, and others. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA. 

On the basis of product type, the market is fragmented into hypoglossal neurostimulation devices, phrenic nerve stimulator, and others. The others segment is projected to exhibit the fastest market growth during the forecast period, owing to the advantages offered by the devices like palatal implant devices and flexible tongue retractor system that are used to treat pharyngeal tone and stimulation of genioglossus protrusion to open the airway by the tongue during sleep.  

These devices reduce the risk of severe dysphagia and throat pain that is witnessed by a surge in the demand for the device in the market. Moreover, the increase in the prevalence of sleeping disorders among the population, surge in the healthcare expenditure, and rise in the adoption of sleep apnea implant products augment the growth of the market. 

On the basis of indication, the market is bifurcated into obstructive sleep apnea and central sleep apnea. The obstructive sleep apnea segment is anticipated to grow at the highest rate, owing to upsurge in demand for sleep apnea implant devices and increase in the number of patients of the sleep disorders, and rise in the number of new product launches. Moreover, factors such as the widespread use of implant devices and the increase in the snoring problems among the population help in the growth of the market. For instance, in May 2021, ResMed, announced the launch of AirSense 11. It was the company’s next-generation PAP (positive airway pressure) device designed to help hundreds of millions of people worldwide with sleep apnea start and stay on therapy to treat and manage obstructive sleep apnea. AirSense 11 included new features such as Personal Therapy Assistant and Care Check-In designed to provide tailored guidance to PAP users, helping ease them into therapy and comfortable nightly use. Other features include the availability of remote software updates so users can enjoy the latest version of these tools every night.  

On the basis of end user, the market is classified into hospitals, ambulatory surgery centers, and others. The ambulatory surgical centers segment is anticipated to grow at the highest rate, owing to increase in the number of hospitals that gives the care services for the sleep apnea and rise in the awareness regarding the use of sleep apnea devices among the population of developing countries. Moreover, the rise in number of specialty clinics also contributes to the growth of the market.  

On the basis of region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). In 2021, North America was the dominant region and is expected to remain dominant throughout the forecast period, owing to high prevalence rate of sleep disorders, increase in the number market players and surge in the product launches in the region. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, owing to the presence of high populace countries such as India and China, which in turn increases the prevalence rate of sleep apnea and the increasing number of strategies and trends adopted by the Sleep Apnea Implants Industry. 

Key findings of the study 

• By product type, the hypoglossal neurostimulation devices segment accounted for major Sleep Apnea Implants Market Share of the sleep apnea implants market in 2021.  

• By indication, the obstructive sleep apnea segment is anticipated to grow with the highest CAGR throughout the forecast period. 

• By end user, the ambulatory surgical centers segment is anticipated to grow with the highest CAGR throughout the forecast period. 

• By region, North America occupied major share of the sleep apnea implants market in 2021.